Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Triple-Negative Breast Carcinoma · Refractory Triple-Negative Breast Carcinoma · Unresectable Triple-Negative Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Emory University Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Shipra Gandhi, MD, MS)Roswell Park Cancer Institute, Buffalo, New York, United States
Study leads
Shipra Gandhi, MD, MS
Principal Investigator
Emory University Hospital/Winship Cancer Institute